Project

A Phase 1 Study of ANV419 as Monotherapy, and ANV419 in Combination With Daratumumab or With Lenalidomide Plus Low-Dose Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma

Aborted - recruitment active · 2023 until 2025

Hess Dagmar, Hutter Franziska